MinorEnrollment closed, study ongoingShow 5 more changesShow less
Study completion pushed from Aug 30, 2026 to May 30, 2027
Secondary endpoints: details revised at 7 of 28 entries
Site details revised
Publications: details revised at 1 of 1 entry
Study description expanded, about 4 words
Study First Submitted
Minor: routine updates
Endpoints
Primary
Diagnostic Performance of Machine Learning Analysis of Finger Photoplethysmography for Detection of Coronary Artery Disease (CAD-RADS ≥2)
Timeframe: Typically within 1 months of enrollment.
Long-Term Incident Major Adverse Renal and Cardiovascular Events (MARCE)
Timeframe: 3-8 years
Immune Activation Biomarkers and Prevalent Atherosclerotic Cardiovascular Disease
Timeframe: Typically within 1 months of enrollment
Lipid Mediator Profiles and Prevalent Atherosclerotic Cardiovascular Disease
Timeframe: Typically within 1 months of enrollment
Correlation Between Oral Microbiota Composition and Prevalent Coronary Artery Disease
Timeframe: Typically within 1 months of enrollment
Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Timeframe: Typically within 1 months of enrollment
Prevalence of Abdominal Aortic Aneurysm
Timeframe: Typically within 1 months of enrolment
Secondary (28)
Multimodal artificial intelligence (AI) model for prediction of coronary artery disease (CAD)
Photoplethysmograpy (PPG) to predict prevalent coronary artery disease
Incremental Predictive Value of Photoplethysmography Beyond Traditional Cardiovascular Risk Models
Lipid Mediator Profiles and Coronary Artery Disease Severity
Arterial stiffness
Show 23 moreShow less
Prevalence of valvular disease and aortic calcification
Machine learning to predict aortic and mitral valve disease
Agreement between CCTA and cardiac doppler ultrasound
Photoplethysmography (PPG) and aortic valve disease
Prevalence and predictors of thoracic aortic dilatation
Left ventricular mass and hypertension
Left ventricular and left atrial strain
Correlation between arterial stiffness and left ventricular hypertrophy
Photoplethysmography and cardiac function
Prevalence of hepatic fibrosis
Predictors of hepatic disease
Prevalence of abdominal aortic subaneurysm
Predictors and factors associated with infrarenal aortic diameter
Association of oral dysbiosis and proteome deregulation with respiratory health, lung imaging, lung function and respiratory symptoms.
Prevalence of oral dysbiosis and proteome deregulation, and their associations with airway diseases such as asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, and lung parenchymal diseases.
Association of oral dysbiosis and proteome deregulation with respiratory health and systemic inflammation
Association of oral dysbiosis and proteome deregulation with respiratory health and comorbidities
Targeted plasma inflammatory markers to predict prevalent coronary artery disease
Gene expression profiling in peripheral blood mononuclear cells (PBMC) and remnant cholesterol
Additional value of Plasma Apolipoproteins to Predict Prevalent Coronary Artery Disease
Prevalence of lipid composition
Erythrocyte Dysfunction and Coronary Artery Disease
Machine learning of photoplethysmography (PPG) to predict mitral valve disease
Arms and interventions
SCAPIS Stockholm reexamination substudy
In SCAPIS (2014 -2018) 30.000 randomly selected adults between the ages of 50 - 64 were included. SCAPIS Reexamination is the re-assessment study of half of the original study cohort. In Stockholm (Danderyd University Hospital site) that corresponds to 2500 adults that are now between 6-10 years older than in the first SCAPIS study. The present study is a prospective, observational substudy of a convenient sample from the SCAPIS reexamination in Stockholm.